Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease

被引：0
|
作者：
Min Jeong Wang
SangHak Yi
Jee-young Han
So Young Park
Jae-Won Jang
In Kook Chun
Sang Eun Kim
Byoung Sub Lee
Gwang Je Kim
Ji Sun Yu
Kuntaek Lim
Sung Min Kang
Young Ho Park
Young Chul Youn
Seong Soo A. An
SangYun Kim
机构：
[1] Seoul National University Bundang Hospital and Seoul National University College of Medicine,Department of Neurology
[2] Kangwon National University Hospital,Department of Neurology
[3] Kangwon National University Hospital and School of Medicine,Department of Nuclear Medicine
[4] Kangwon National University,Department of Nuclear Medicine
[5] Seoul National University Bundang Hospital and Seoul National University College of Medicine,Department of Research and Development
[6] PeopleBio,Department of Neurology
[7] Inc,Department of Bionano Technology, Gachon Medical Research Institute
[8] Chung-Ang University Hospital,undefined
[9] Gachon University,undefined
来源：
Alzheimer's Research & Therapy | / 9卷
关键词：
Amyloid-β protein; Oligomer; Alzheimer’s disease; Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Amyloid-β as a Blood Biomarker for Alzheimer's Disease: A Review of Recent Literature
    Wang, Xiaoni
    Sun, Yu
    Li, Taoran
    Cai, Yanning
    Han, Ying
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (03) : 819 - 832
  • [12] Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
    El-Agnaf, Omar M. A.
    Salem, Sultan A.
    Paleologou, Katerina E.
    Curran, Martin D.
    Gibson, Mark J.
    Court, Jennifer A.
    Schlossmacher, Michael G.
    Allsop, David
    FASEB JOURNAL, 2006, 20 (03): : 419 - 425
  • [13] Is a blood-based biomarker the future for Alzheimer's disease diagnosis?
    不详
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2013, 3 (05) : 404 - 404
  • [14] Is a blood-based biomarker the future for Alzheimer's disease diagnosis?
    Webb, Elizabeth
    BIOMARKERS IN MEDICINE, 2013, 7 (05) : 684 - 684
  • [15] Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-β peptide
    Karr, Jesse W.
    Szalai, Veronika A.
    BIOCHEMISTRY, 2008, 47 (17) : 5006 - 5016
  • [16] ALZHEIMER DISEASE The search for a blood-based biomarker for Alzheimer disease
    Rembach, Alan
    NATURE REVIEWS NEUROLOGY, 2014, 10 (11) : 618 - 619
  • [17] Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
    Pyun, Jung-Min
    Youn, Young Chul
    Park, Young Ho
    Kim, SangYun
    FRONTIERS IN NEUROLOGY, 2023, 13
  • [18] Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease
    Lim, Yen Ying
    Maruff, Paul
    Kaneko, Naoki
    Doecke, James
    Fowler, Christopher
    Villemagne, Victor L.
    Kato, Takashi
    Rowe, Christopher C.
    Arahata, Yutaka
    Iwamoto, Shinichi
    Ito, Kengo
    Tanaka, Koichi
    Yanagisawa, Katsuhiko
    Masters, Colin L.
    Nakamura, Akinori
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 77 (03) : 1057 - 1065
  • [19] Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer's Disease: A Blinded Validation Study
    Youn, Young Chul
    Lee, Byoung Sub
    Kim, Gwang Je
    Ryu, Ji Sun
    Lim, Kuntaek
    Lee, Ryan
    Suh, Jeewon
    Park, Young Ho
    Pyun, Jung-Min
    Ryu, Nayoung
    Kang, Min Ju
    Kim, Hye Ryoun
    Kang, Sungmin
    An, Seong Soo A.
    Kim, SangYun
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (02) : 493 - 499
  • [20] The search for a blood-based biomarker for Alzheimer disease
    Alan Rembach
    Nature Reviews Neurology, 2014, 10 : 618 - 619
12345